Foodborne transmission of bovine spongiform encephalopathy to nonhuman primates.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 3647490)

Published in Emerg Infect Dis on May 01, 2013

Authors

Edgar Holznagel1, Barbara Yutzy, Walter Schulz-Schaeffer, Carina Kruip, Uwe Hahmann, Pär Bierke, Juan-Maria Torres, Yong-Sun Kim, Achim Thomzig, Michael Beekes, Gerhard Hunsmann, Johannes Loewer

Author Affiliations

1: Paul-Ehrlich-Institut, Langen, Germany. holed@pei.de

Articles cited by this

A new variant of Creutzfeldt-Jakob disease in the UK. Lancet (1996) 20.15

Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature (1997) 15.73

Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature (1996) 14.40

Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol (1999) 6.98

Phosphorylation affects the ability of tau protein to promote microtubule assembly. J Biol Chem (1984) 3.36

Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol (2005) 2.91

Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol (2004) 2.47

Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A (2000) 2.46

Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. Brain (2009) 2.12

Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study. Lancet Neurol (2009) 1.94

Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom. Science (2001) 1.93

The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Am J Pathol (2000) 1.91

Variant CJD in an individual heterozygous for PRNP codon 129. Lancet (2009) 1.84

Risk of oral infection with bovine spongiform encephalopathy agent in primates. Lancet (2005) 1.82

Detection of type 1 prion protein in variant Creutzfeldt-Jakob disease. Am J Pathol (2006) 1.80

Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease. J Biol Chem (2003) 1.61

Classification of sporadic Creutzfeldt-Jakob disease revisited. Brain (2006) 1.54

Effect of repeated oral infection of hamsters with scrapie. J Gen Virol (1998) 1.44

Increase in CD230 (cellular prion protein) fluorescence on blood lymphocytes in bovine spongiform encephalopathy-infected nonhuman primates. Transfusion (2009) 1.41

Characterization of truncated forms of abnormal prion protein in Creutzfeldt-Jakob disease. J Biol Chem (2008) 1.40

Early detection of PrPres in BSE-infected bovine PrP transgenic mice. Arch Virol (2003) 1.34

Reciprocal interference between specific CJD and scrapie agents in neural cell cultures. Science (2005) 1.34

Susceptibilities of nonhuman primates to chronic wasting disease. Emerg Infect Dis (2009) 1.33

Coinfecting prion strains compete for a limiting cellular resource. J Virol (2010) 1.32

Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. BMJ (2006) 1.28

Generation of monoclonal antibody recognized by the GXXXG motif (glycine zipper) of prion protein. Hybridoma (Larchmt) (2006) 1.13

Repeated challenge with prion disease: the risk of infection and impact on incubation period. Proc Natl Acad Sci U S A (2003) 1.01

Large-scale immunohistochemical examination for lymphoreticular prion protein in tonsil specimens collected in Britain. J Pathol (2010) 0.94

Time-course studies of 14-3-3 protein isoforms in cerebrospinal fluid and brain of primates after oral or intracerebral infection with bovine spongiform encephalopathy agent. J Gen Virol (2007) 0.92

Population distribution of the methionine allele at the PRNP codon 129 polymorphism in Europe and the Middle East. Hum Biol (2008) 0.87

Articles by these authors

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Lancet Neurol (2011) 3.12

Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration. Exp Neurol (2008) 2.31

Formal protocol for emergency treatment of ruptured intracranial aneurysms to reduce in-hospital rebleeding and improve clinical outcomes. J Neurosurg (2014) 2.04

MHC class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys. J Immunol (2002) 1.97

High prevalence of leukoaraiosis in cerebral magnetic resonance images of patients on peritoneal dialysis. Am J Kidney Dis (2007) 1.88

LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide. Brain (2005) 1.81

Pre-symptomatic detection of prions by cyclic amplification of protein misfolding. FEBS Lett (2005) 1.77

Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol (2004) 1.74

Scrapie Agent (Strain 263K) can transmit disease via the oral route after persistence in soil over years. PLoS One (2007) 1.72

Screening of innate immune receptors in neurodegenerative diseases: a similar pattern. Neurobiol Aging (2007) 1.62

Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress. FASEB J (2002) 1.52

Decontamination of surgical instruments from prion proteins: in vitro studies on the detachment, destabilization and degradation of PrPSc bound to steel surfaces. J Gen Virol (2004) 1.48

Acute serious rebleeding after angiographically successful coil embolization of ruptured cerebral aneurysms. Acta Neurochir (Wien) (2010) 1.42

Increase in CD230 (cellular prion protein) fluorescence on blood lymphocytes in bovine spongiform encephalopathy-infected nonhuman primates. Transfusion (2009) 1.41

Discriminating scrapie and bovine spongiform encephalopathy isolates by infrared spectroscopy of pathological prion protein. J Biol Chem (2004) 1.41

Kir potassium channel subunit expression in retinal glial cells: implications for spatial potassium buffering. Glia (2002) 1.36

The Hedgehog receptor Patched controls lymphoid lineage commitment. Blood (2007) 1.35

Chloroquine activates the p53 pathway and induces apoptosis in human glioma cells. Neuro Oncol (2010) 1.33

Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severity. Neurosci Lett (2004) 1.33

Widespread PrPSc accumulation in muscles of hamsters orally infected with scrapie. EMBO Rep (2003) 1.31

Antitumor effects of a combined 5-aza-2'deoxycytidine and valproic acid treatment on rhabdomyosarcoma and medulloblastoma in Ptch mutant mice. Cancer Res (2009) 1.30

Autocatalytic self-propagation of misfolded prion protein. Proc Natl Acad Sci U S A (2004) 1.30

Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QUIC assay. PLoS One (2013) 1.30

Deletion of cellular prion protein results in reduced Akt activation, enhanced postischemic caspase-3 activation, and exacerbation of ischemic brain injury. Stroke (2006) 1.29

Human-specific subfamilies of HERV-K (HML-2) long terminal repeats: three master genes were active simultaneously during branching of hominoid lineages. Genomics (2003) 1.28

Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol (2009) 1.27

Is there a risk of prion-like disease transmission by Alzheimer- or Parkinson-associated protein particles? Acta Neuropathol (2014) 1.24

Genome-wide targeted search for human specific and polymorphic L1 integrations. Hum Genet (2003) 1.23

Preclinical deposition of pathological prion protein PrPSc in muscles of hamsters orally exposed to scrapie. J Clin Invest (2004) 1.21

Generation of genuine prion infectivity by serial PMCA. Vet Microbiol (2007) 1.19

Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA. Korean J Radiol (2005) 1.17

Emergence of classical BSE strain properties during serial passages of H-BSE in wild-type mice. PLoS One (2011) 1.15

Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease. Arch Neurol (2006) 1.15

Structural differences between TSEs strains investigated by FT-IR spectroscopy. Biochim Biophys Acta (2006) 1.14

Generation of monoclonal antibody recognized by the GXXXG motif (glycine zipper) of prion protein. Hybridoma (Larchmt) (2006) 1.13

Accumulation of pathological prion protein PrPSc in the skin of animals with experimental and natural scrapie. PLoS Pathog (2007) 1.08

Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease. Mol Neurodegener (2009) 1.07

A technique for genome-wide identification of differences in the interspersed repeats integrations between closely related genomes and its application to detection of human-specific integrations of HERV-K LTRs. Genomics (2002) 1.07

Quantitative detection and biological propagation of scrapie seeding activity in vitro facilitate use of prions as model pathogens for disinfection. PLoS One (2011) 1.05

Faecal shedding, alimentary clearance and intestinal spread of prions in hamsters fed with scrapie. Vet Res (2008) 1.05

Cell-free formation of misfolded prion protein with authentic prion infectivity. Proc Natl Acad Sci U S A (2006) 1.05

Progressive loss of a glial potassium channel (KCNJ10) in the spinal cord of the SOD1 (G93A) transgenic mouse model of amyotrophic lateral sclerosis. J Neurochem (2006) 1.04

Switching strategy for mechanical thrombectomy of acute large vessel occlusion in the anterior circulation. Stroke (2013) 1.04

The cellular prion protein (PrPC) prevents apoptotic neuronal cell death and mitochondrial dysfunction induced by serum deprivation. Brain Res Mol Brain Res (2004) 1.03

Time-point and dosage of gene inactivation determine the tumor spectrum in conditional Ptch knockouts. Carcinogenesis (2009) 1.03

Decontamination of medical devices from pathological amyloid-β-, tau- and α-synuclein aggregates. Acta Neuropathol Commun (2014) 1.03

The prevalence of human endogenous retroviruses in cerebrospinal fluids from patients with sporadic Creutzfeldt-Jakob disease. J Clin Virol (2009) 1.02

Transcranial direct current stimulation induces polarity-specific changes of cortical blood perfusion in the rat. Exp Neurol (2010) 1.02

Detection of prion particles in samples of BSE and scrapie by fluorescence correlation spectroscopy without proteinase K digestion. Biol Chem (2006) 1.00

Sall1, sall2, and sall4 are required for neural tube closure in mice. Am J Pathol (2008) 0.99

Association of sporadic Creutzfeldt-Jakob disease with homozygous genotypes at PRNP codons 129 and 219 in the Korean population. Neurogenetics (2005) 0.98

Redox metals and oxidative abnormalities in human prion diseases. Acta Neuropathol (2005) 0.98

Pathological prion protein in muscles of hamsters and mice infected with rodent-adapted BSE or vCJD. J Gen Virol (2006) 0.97

Fast, broad-range disinfection of bacteria, fungi, viruses and prions. J Gen Virol (2009) 0.97

Accumulation of citrullinated proteins by up-regulated peptidylarginine deiminase 2 in brains of scrapie-infected mice: a possible role in pathogenesis. Am J Pathol (2008) 0.97

N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus. J Hepatol (2010) 0.97

Identification of variants in cyclin D1 ( CCND1) and B-Cell CLL/lymphoma 2 ( BCL2). J Hum Genet (2004) 0.95

Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model. Vaccine (2005) 0.95

Activation of mitogen-activated protein kinases in hamster brains infected with 263K scrapie agent. J Neurochem (2005) 0.95

Brain biopsy in patients with suspected Creutzfeldt-Jakob disease. J Neurosurg (2008) 0.95

The pathogenic mechanisms of prion diseases. Mech Ageing Dev (2002) 0.94

In situ identification of protein structural changes in prion-infected tissue. Biochim Biophys Acta (2003) 0.94

Effect of transition metals (Mn, Cu, Fe) and deoxycholic acid (DA) on the conversion of PrPC to PrPres. FASEB J (2005) 0.94

The involvement of cellular prion protein in the autophagy pathway in neuronal cells. Mol Cell Neurosci (2008) 0.93

Polymorphisms of the prion protein gene (PRNP) in a Korean population. J Hum Genet (2004) 0.93

Similarities between forms of sheep scrapie and Creutzfeldt-Jakob disease are encoded by distinct prion types. Am J Pathol (2009) 0.93

Time-course studies of 14-3-3 protein isoforms in cerebrospinal fluid and brain of primates after oral or intracerebral infection with bovine spongiform encephalopathy agent. J Gen Virol (2007) 0.92

JAK-STAT signaling pathway mediates astrogliosis in brains of scrapie-infected mice. J Neurochem (2007) 0.92

Scrapie infection activates the replication of ecotropic, xenotropic, and polytropic murine leukemia virus (MuLV) in brains and spinal cords of senescence-accelerated mice: implication of MuLV in progression of scrapie pathogenesis. Biochem Biophys Res Commun (2006) 0.92

Rescue forced-suction thrombectomy using the reperfusion catheter of the Penumbra System for thromboembolism during coil embolization of ruptured cerebral aneurysms. Neurosurgery (2012) 0.92

Optimized high-resolution mapping of magnetization transfer (MT) at 3 Tesla for direct visualization of substructures of the human thalamus in clinically feasible measurement time. J Magn Reson Imaging (2009) 0.92

Correlations between neuronal loss, decrease of memory, and decrease expression of brain-derived neurotrophic factor in the gerbil hippocampus during normal aging. Exp Neurol (2006) 0.91

Decontamination of surgical instruments from prions. II. In vivo findings with a model system for testing the removal of scrapie infectivity from steel surfaces. J Gen Virol (2008) 0.91

Tumor stroma-derived Wnt5a induces differentiation of basal cell carcinoma of Ptch-mutant mice via CaMKII. Cancer Res (2010) 0.91

Preclinical deposition of pathological prion protein in muscle of experimentally infected primates. PLoS One (2010) 0.91

Establishment and characterization of Prnp knockdown neuroblastoma cells using dual microRNA-mediated RNA interference. Prion (2011) 0.91

FTIR-microspectroscopy of prion-infected nervous tissue. Biochim Biophys Acta (2006) 0.90

Familial Creutzfeldt-Jakob disease with V180I mutation. J Korean Med Sci (2010) 0.90

Phospholipase D1 is associated with amyloid precursor protein in Alzheimer's disease. Neurobiol Aging (2006) 0.90

Reduction of prion infectivity and levels of scrapie prion protein by lithium aluminum hydride: implications for RNA in prion diseases. J Neuropathol Exp Neurol (2009) 0.90

Oxidative stress impairs autophagic flux in prion protein-deficient hippocampal cells. Autophagy (2012) 0.90

Antemortem identification of bovine spongiform encephalopathy from serum using infrared spectroscopy. Anal Chem (2003) 0.90

HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus. Biochem Biophys Res Commun (2004) 0.90

Identification of scrapie infection from blood serum by Fourier transform infrared spectroscopy. Anal Chem (2002) 0.90

Early ventriculoperitoneal shunt placement after severe aneurysmal subarachnoid hemorrhage: role of intraventricular hemorrhage and shunt function. Neurosurgery (2010) 0.90

Involvement of peptidylarginine deiminase-mediated post-translational citrullination in pathogenesis of sporadic Creutzfeldt-Jakob disease. Acta Neuropathol (2009) 0.90

Outcome of forced-suction thrombectomy in acute intracranial internal carotid occlusion. J Neurointerv Surg (2012) 0.89